Advancing Healthcare with Precision Medicine and AI-Driven Optimization
Stay ahead of the curve on our latest innovations. Subscribe now to receive regular Pharma updates and stay informed.
Don't miss our latest presentation on Fully Automation NASH Quantification using Deep Learning Applications, which was delivered at the 6th Global NASH Congress in London in March 2023.
We hope you enjoy it!
Precision Medicine Transformation & Drug Development Optimization
Shift to precision medicine paradigm.
We leverage our unique combination of digital pathology platform and AI expertise to enhance translational, preclinical and clinical research for biomarker screening and response predictions to treatments on a targeted populations. We help our pharmaceutical, CRO and biotech partners to develop new AI models to better understand multiple diseases and find targeted treatments. Therapeutic areas include oncology (GI, NSCLC, breast, HNSCC...) and inflammatory diseases , such as Inflammatory Bowel Disease (IBD), Non-Alcoholic Steato-Hepatitis (NASH) …
De-risk clinical studies.
Leverage from our central digital pathology platform to refine patients stratification strategies and increase your success rates for clinical studies. Patient inclusion into clinical studies will be optimised to avoid inefficient recruitment and clinical study failures due to poor responses to new therapies. Digital Pathology is becoming a key component for personalized healthcare and is driving critical therapeutic decisions for better patient outcomes. Digital Pathology represents a powerful emerging approach to classify cellular interactions and signaling by identifying relevant phenotyping and spatial relationships.
Access to real world pathology data and cohort builder.
As an expert of pathology data workflow, we leverage our digital pathology suite and hospitals/private labs network to access real world pathology data. This allows us to : (1) help you select the right sites for your clinical studies, (2) build patient's cohort based on reliable pathomics data for synthetic control arms.
Deploy and commercialize your companion diagnostics.
We support you with the development of your AI model and CDx from scratch using our AI expert team and innovative learning methodologies. We help you to deploy your CDx through our AI marketplace linked to our digital pathology suite. Our diverse and broad hospitals network can access your CDx for quicker diagnostics and treatment decision facilitating novel therapy adoption. We're your partner of choice for CDx development and commercialization.